Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Gastrointestinal disorders

Gastrointestinal disorders

18-05-2018 | Nutritional management | Article

Adherence to special diets and its association with meeting the nutrient recommendations in individuals with type 1 diabetes

Ahola AJ, Forsblom C, Groop PH. Acta Diabetol 2018. doi: 10.1007/s00592-018-1159-2

18-04-2018 | Artificial pancreas systems | Article

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis

Bekiari E et al. BMJ 2018; 361: k1310. doi: 10.1136/bmj.k1310 

29-03-2018 | Diagnosis | Case report | Article

Prediabetes directly deteriorates into diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome triggered by acute pancreatitis: A case report illustrating a “chicken and egg” paradigm in ketosis-prone diabetes

Song R, Cao S. Diabetes Ther 2018; 9: 1377. doi: 10.1007/s13300-018-0417-1

20-03-2018 | Diet | News

DiRECT: Effects on insulin and liver fat revealed

Researchers from the DiRECT trial have reported large positive effects on liver fat and insulin secretion among people who achieved type 2 diabetes remission in response to a very-low-calorie diet.

07-02-2018 | Risk factors | Highlight | News

‘Subtle’ metabolic derangement seen decades before diabetes diagnosis

Research shows that changes in markers of the metabolic syndrome and fatty liver disease are present more than 20 years before people receive a diagnosis of type 2 diabetes.

29-12-2017 | Nephropathy | Review | Article

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

Nat Rev Endocrinol 2017; 14: 99–114. doi: 10.1038/nrendo.2017.173

27-10-2017 | Risk factors | Review | Article

Diabetes and the pancreatobiliary diseases

Shafqet M, Sharzehi K. Curr Treat Options Gastro 2017; 15: 508–519. doi: 10.1007/s11938-017-0163-x

06-10-2017 | Gastrointestinal disorders | Article

Screening for celiac disease in poorly controlled type 2 diabetes mellitus: Worth it or not?

Kizilgul M et al. BMC Endocr Disord 2017; 17: 62. doi: 10.1186/s12902-017-0212-4

20-09-2017 | Non-alcoholic fatty liver disease | EASD 2017 | News

NAFLD: The associated risks and potential treatments

Researchers presented the results of several studies investigating the risks associated with nonalcoholic fatty liver disease and potential treatment strategies at the EASD annual meeting in Lisbon, Portugal.

13-09-2017 | Diet | EASD 2017 | News

Hypocaloric low-fat and low-carbohydrate diets beneficial in type 2 diabetes

Results of a randomized trial suggest that patients with type 2 diabetes experience metabolic benefits from a hypocaloric diet regardless of whether it is low in fat or low in carbohydrate content.

03-08-2017 | Ipragliflozin | News

Ipragliflozin and pioglitazone ‘equally beneficial’ for type 2 diabetes with NAFLD

Results of a randomized trial suggest that the sodium-glucose cotransporter 2 inhibitor ipragliflozin has equivalent efficacy to pioglitazone for the treatment of patients with type 2 diabetes complicated by nonalcoholic fatty liver disease.

18-07-2017 | Gastrointestinal disorders | Review | Article

Gastroparesis: Medical and therapeutic advances

Navas CM, Patel NK, Lacy BE. Dig Dis Sci 2017; 62: 2231–2240. doi: 10.1007/s10620-017-4679-7

27-01-2017 | Gastroparesis | Book chapter | Article

Diabetic gastroparesis

Tansel A, Husain N. In: Managing Gastrointestinal Complications of Diabetes. Edited by Sellin J. Adis, Cham, 2017. doi: 10.1007/978-3-319-48662-8_3

21-01-2017 | Gastrointestinal disorders | Article

The burdens, concerns, and quality of life of patients with gastroparesis

Yu D et al. Dig Dis Sci 2017; 62: 879–893. doi: 10.1007/s10620-017-4456-7

18-07-2016 | Gastrointestinal disorders | Practical approach | Article

A practical approach to gastrointestinal complications of diabetes

This article reviews the pathophysiology, clinical presentation, epidemiology, and management of diabetic enteropathy, aiming to provide a practical approach to this often under-recognized and challenging complication of diabetes.

Previous
Image Credits